Connection

Federico Diotallevi to Psoriasis

This is a "connection" page, showing publications Federico Diotallevi has written about Psoriasis.
Connection Strength

0.747
  1. Vaccination against SARS-CoV-2 and psoriasis: the three things every dermatologist should know. J Eur Acad Dermatol Venereol. 2021 Jul; 35(7):e428-e430.
    View in: PubMed
    Score: 0.325
  2. Ixekizumab for treatment of moderate to severe plaque psoriasis: real world clinical experience. G Ital Dermatol Venereol. 2020 Dec; 155(6):739-743.
    View in: PubMed
    Score: 0.275
  3. A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic. J Eur Acad Dermatol Venereol. 2021 Mar; 35(3):e169-e170.
    View in: PubMed
    Score: 0.079
  4. Skin involvement in patients with psoriatic arthritis: preliminary results of treatment with apremilast in real world setting. G Ital Dermatol Venereol. 2019 Apr; 154(2):166-169.
    View in: PubMed
    Score: 0.068
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.